Skip to main content

TWO SIGMA INVESTMENTS, LP

Position in FATE — Fate Therapeutics Inc

CIK 1179392 NEW YORK, NY

Position in FATE

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$4,160,143
+$2,460,761 QoQ
Shares Held
3,466,786
+99.9% QoQ
Ownership
2.97%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
22 quarters on record
Voting authority Sole 97.83661293197792.ToString("F0")% Shared 0.ToString("F0")% None 2.1633870680220815.ToString("F0")%

Common Shares in FATE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

TWO SIGMA INVESTMENTS, LP holds $5,506,832,621 across 316 Biotechnology names. FATE ranks #108 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in FATE

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $4,160,143 3,466,786
2025-12-31 $1,699,382 1,734,064
2025-09-30 $1,134,953 900,757
2025-06-30 $255,813 228,405
2025-03-31 $191,078 241,872
2024-12-31 $490,224 297,106
2024-09-30 $1,608,477 459,565
2024-06-30 $3,345,557 1,019,987
2024-03-31 $1,945,100 265,000
2023-12-31 $5,799,464 1,550,659
2023-09-30 $3,500,696 1,651,272
2023-06-30 $9,127,514 1,917,545
2023-03-31 $10,277,573 1,803,083
2022-12-31 $15,172,837 1,503,750
2022-09-30 $4,236,991 189,067
2021-12-31 $860,097 14,700
2021-09-30 $17,753,854 299,542
2021-06-30 $25,435,979 293,075
2021-03-31 $54,382,618 659,583
2020-12-31 $29,310,558 322,342
2020-09-30 $14,745,892 368,924
2020-06-30 $7,444,000 216,963